Immunome, Inc. · NASDAQ:IMNM
T. Rowe Price Investment Management, Inc. reported a 12.20% stake in Immunome, Inc. (Schedule 13G)
Event Oct 31, 2025 · Filed Nov 7, 2025
T. Rowe Price Investment Management, Inc. reported a 12.20% stake in Immunome, Inc., 10,644,674 shares, as a passive investor on Oct 31, 2025. Filed Nov 7, 2025 (Schedule 13G).
- Stake
- 12.20%
- Shares
- 10,644,674
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| T. Rowe Price Investment Management, Inc. | 12.20% | 10,644,674 |
Source
Related
- Immunome, Inc.
- T. Rowe Price Investment Management, Inc.
- Immunome, Inc. shareholders
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Aug 14, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · May 15, 2026
- Form 4 · Higgins Jack · Sep 15, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026
- Form 4 · Barchas Isaac · Aug 12, 2026
- Form 4 · Barchas Isaac · Aug 10, 2026
- Form 4 · Horn Kinney · Aug 6, 2026